L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome

@article{Spinelli2010L41QPO,
  title={L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome},
  author={Letizia Spinelli and Valentina Trimarco and Serena Di Marino and Marina Marino and Guido Iaccarino and Bruno Trimarco},
  journal={European Journal of Heart Failure},
  year={2010},
  volume={12}
}
Altered response to acute catecholamine increase in the synaptic cleft is considered to be the mechanism underlying transient left ventricular apical ballooning syndrome (LVABS). –3 Cardiac adrenergic receptors (ARs) of the b1 and b2 subtypes activate myocytes by coupling to the Ga subunit of the heterotrimeric Gs protein, but on the other hand they also promote G protein coupled receptor kinase (GRK)-mediated phosphorylation of bAR with the intent to shut-off signalling. The impact on cardiac… 

G Protein Coupled Receptor Kinases as Therapeutic Targets in Cardiovascular Disease

The role of GRKs in cardiovascular pathophysiology is reviewed, with an emphasis on the role of GPCR second-messenger cascades.

The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

The current data on GRKs related to cardiac disease are reviewed and their potential in the development of novel therapeutic strategies in cardiac diseases including heart failure is discussed.

Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment.

Future efforts to identify the genetic variants in individual drug response to heart failure therapeutics, further underscore the significance of pharmacogenomics and develop the scientific findings of selected gene–drug interactions towards personalized medicine.

Nuclear Effects of G-Protein Receptor Kinase 5 on Histone Deacetylase 5–Regulated Gene Transcription in Heart Failure

GRK5 is a transcriptional modifier of a subset of G&agr;q-downregulated genes, acting in opposition to the pathological effects of G &agr ;q and normalizing levels of these transcripts, and may act in concert with &bgr;-adrenergic receptor desensitization to protect against heart failure decompensation.

Analysis of β1 and β2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy

Beta adrenoreceptors gene polymorphisms are probably disease modifi ers, and any risk estimate should be based on a combination of genotypes and on interactions with other genes and environmental features.

Molecular Mechanisms of Takotsubo Syndrome

The available literature is summarised to focus on the molecular basis for the pathophysiology of TTS to advance the understanding of the condition.

Lack of genetic susceptibility in takotsubo cardiomyopathy: a case-control study

By genotyping a large takotsubo cohort, a lack of association between candidate SNPs in the ADRB1, GRK5 and BAG3 genes is demonstrated, indicating a need to expand the search for new genetic candidates contributing to TCM.

Nuclear Effects of GRK5 on HDAC5-regulated Gene Transcription in Heart Failure

GRK5 is a transcriptional modifier of a sub-set of Gαq-downregulated genes, acting in opposition to the pathological effects of G αq and normalizing levels of these transcripts, and may act in concert with β-adrenergic receptor desensitization to protect against heart failure decompensation.

"Canonical and non-canonical actions of GRK5 in the heart".

...

References

SHOWING 1-10 OF 14 REFERENCES

Myocardial G protein-coupled receptor kinases: implications for heart failure therapy.

The compelling finding that inhibition of beta ARK1 activity or expression significantly enhances cardiac function and potentiates beta AR signaling in failing cardiomyocytes is addressed.

Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown.

  • S. Liggett
  • Biology
    The Journal of clinical investigation
  • 2001
Results indicate that although β1AR and β2AR each couple to Gs, these receptor subtypes must engage distinct signaling pathways, and that cAMP alone may not be the only second messenger that is necessary for adrenergic mediated toxic effects.

A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure

Enhanced βAR desensitization of excessive catecholamine signaling by GRK5-Leu41 provides a 'genetic β-blockade' that improves survival in African Americans with heart failure, suggesting a reason for conflicting results of β-Blocker clinical trials in this population.

Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning

It is hypothesized that stress cardiomyopathy is a form of myocardial stunning, but with different cellular mechanisms to those seen during transient episodes of ischemia secondary to coronary stenoses, and that high levels of circulating epinephrine trigger a switch in intracellular signal trafficking in ventricular cardiomeocytes, from Gs protein to Gi protein signaling via the β2-adrenoceptor.

Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.

The biological basis of adrenergic signaling and how this changes in heart failure is discussed, and recently emerging differences described for beta(1)- v beta(2)-AR signaling pathways are highlighted.

Association of a GNAS1 gene variant with hypertension and diabetes mellitus.

Results did not support the hypothesis that the interaction between the T393C polymorphism and GGT in the association with hypertension could be caused by an indirect effect of Gs proteins mediated by glucose metabolism, and examined the possible interaction between gamma-glutamyl transpeptidase (GGT), which is an established biomarker of alcohol consumption, in the associations with glucose metabolism as well as with hypertension in a Japanese population.

Can takotsubo cardiomyopathy be familial?

Neurohumoral features of myocardial stunning due to sudden emotional stress.

Emotional stress can precipitate severe, reversible left ventricular dysfunction in patients without coronary disease andaggerated sympathetic stimulation is probably central to the cause of this syndrome.

alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans.

Responses to alpha-adrenoceptor activation are augmented in the presence of coronary endothelial dysfunction and atherosclerosis, involving both alpha(1)- and alpha(2)- adrenoceptors in epicardial conduit arteries and microvessels, and it is powerful enough to induce myocardial ischemia and limit myocardIAL function.

Myocardial perfusion in apical ballooning syndrome correlate of myocardial injury.